Global Human Coagulation Factor VIII Market Analysis and Forecast 2024-2030
Summary
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, The global Human Coagulation Factor VIII market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Coagulation Factor VIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Coagulation Factor VIII, also provides the sales of main regions and countries. Of the upcoming market potential for Human Coagulation Factor VIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Coagulation Factor VIII sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Coagulation Factor VIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Coagulation Factor VIII sales, projected growth trends, production technology, application and end-user industry.
Human Coagulation Factor VIII segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Human Coagulation Factor VIII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VIII sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, The global Human Coagulation Factor VIII market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Coagulation Factor VIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Coagulation Factor VIII, also provides the sales of main regions and countries. Of the upcoming market potential for Human Coagulation Factor VIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Coagulation Factor VIII sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Coagulation Factor VIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Coagulation Factor VIII sales, projected growth trends, production technology, application and end-user industry.
Human Coagulation Factor VIII segment by Company
- Shire (Baxter)
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
- Recombinant Factor VIII
- Plasma-derived Factor VIII
- Hemophilia A
- Spontanous / Trauma
- Surgical
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Human Coagulation Factor VIII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VIII sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Human Coagulation Factor VIII Market by Type
1.2.1 Global Human Coagulation Factor VIII Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII Market by Application
1.3.1 Global Human Coagulation Factor VIII Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HUMAN COAGULATION FACTOR VIII MARKET DYNAMICS
2.1 Human Coagulation Factor VIII Industry Trends
2.2 Human Coagulation Factor VIII Industry Drivers
2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
2.4 Human Coagulation Factor VIII Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Human Coagulation Factor VIII Revenue Estimates and Forecasts (2019-2030)
3.2 Global Human Coagulation Factor VIII Revenue by Region
3.2.1 Global Human Coagulation Factor VIII Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Human Coagulation Factor VIII Revenue by Region (2019-2024)
3.2.3 Global Human Coagulation Factor VIII Revenue by Region (2025-2030)
3.2.4 Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2030)
3.3 Global Human Coagulation Factor VIII Sales Estimates and Forecasts 2019-2030
3.4 Global Human Coagulation Factor VIII Sales by Region
3.4.1 Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Human Coagulation Factor VIII Sales by Region (2019-2024)
3.4.3 Global Human Coagulation Factor VIII Sales by Region (2025-2030)
3.4.4 Global Human Coagulation Factor VIII Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Human Coagulation Factor VIII Revenue by Manufacturers
4.1.1 Global Human Coagulation Factor VIII Revenue by Manufacturers (2019-2024)
4.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Human Coagulation Factor VIII Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Human Coagulation Factor VIII Sales by Manufacturers
4.2.1 Global Human Coagulation Factor VIII Sales by Manufacturers (2019-2024)
4.2.2 Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Human Coagulation Factor VIII Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Human Coagulation Factor VIII Sales Price by Manufacturers (2019-2024)
4.4 Global Human Coagulation Factor VIII Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Human Coagulation Factor VIII Manufacturers, Product Type & Application
4.7 Global Human Coagulation Factor VIII Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Human Coagulation Factor VIII Market CR5 and HHI
4.8.2 2023 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier
5 HUMAN COAGULATION FACTOR VIII MARKET BY TYPE
5.1 Global Human Coagulation Factor VIII Revenue by Type
5.1.1 Global Human Coagulation Factor VIII Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Human Coagulation Factor VIII Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2030)
5.2 Global Human Coagulation Factor VIII Sales by Type
5.2.1 Global Human Coagulation Factor VIII Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Human Coagulation Factor VIII Sales by Type (2019-2030) & (K Bottles)
5.2.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2030)
5.3 Global Human Coagulation Factor VIII Price by Type
6 HUMAN COAGULATION FACTOR VIII MARKET BY APPLICATION
6.1 Global Human Coagulation Factor VIII Revenue by Application
6.1.1 Global Human Coagulation Factor VIII Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Human Coagulation Factor VIII Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2030)
6.2 Global Human Coagulation Factor VIII Sales by Application
6.2.1 Global Human Coagulation Factor VIII Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Human Coagulation Factor VIII Sales by Application (2019-2030) & (K Bottles)
6.2.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2030)
6.3 Global Human Coagulation Factor VIII Price by Application
7 COMPANY PROFILES
7.1 Shire (Baxter)
7.1.1 Shire (Baxter) Comapny Information
7.1.2 Shire (Baxter) Business Overview
7.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
7.1.5 Shire (Baxter) Recent Developments
7.2 Bayer
7.2.1 Bayer Comapny Information
7.2.2 Bayer Business Overview
7.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
7.2.5 Bayer Recent Developments
7.3 CSL
7.3.1 CSL Comapny Information
7.3.2 CSL Business Overview
7.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 CSL Human Coagulation Factor VIII Product Portfolio
7.3.5 CSL Recent Developments
7.4 Pfizer
7.4.1 Pfizer Comapny Information
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
7.4.5 Pfizer Recent Developments
7.5 Grifols
7.5.1 Grifols Comapny Information
7.5.2 Grifols Business Overview
7.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
7.5.5 Grifols Recent Developments
7.6 Biogen
7.6.1 Biogen Comapny Information
7.6.2 Biogen Business Overview
7.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
7.6.5 Biogen Recent Developments
7.7 Octapharma
7.7.1 Octapharma Comapny Information
7.7.2 Octapharma Business Overview
7.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
7.7.5 Octapharma Recent Developments
7.8 NovoNordisk
7.8.1 NovoNordisk Comapny Information
7.8.2 NovoNordisk Business Overview
7.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
7.8.5 NovoNordisk Recent Developments
7.9 Greencross
7.9.1 Greencross Comapny Information
7.9.2 Greencross Business Overview
7.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
7.9.5 Greencross Recent Developments
7.10 Kedrion
7.10.1 Kedrion Comapny Information
7.10.2 Kedrion Business Overview
7.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
7.10.5 Kedrion Recent Developments
7.11 BPL
7.11.1 BPL Comapny Information
7.11.2 BPL Business Overview
7.11.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 BPL Human Coagulation Factor VIII Product Portfolio
7.11.5 BPL Recent Developments
7.12 Hualan Bio
7.12.1 Hualan Bio Comapny Information
7.12.2 Hualan Bio Business Overview
7.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
7.12.5 Hualan Bio Recent Developments
7.13 RAAS
7.13.1 RAAS Comapny Information
7.13.2 RAAS Business Overview
7.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
7.13.5 RAAS Recent Developments
8 NORTH AMERICA
8.1 North America Human Coagulation Factor VIII Market Size by Type
8.1.1 North America Human Coagulation Factor VIII Revenue by Type (2019-2030)
8.1.2 North America Human Coagulation Factor VIII Sales by Type (2019-2030)
8.1.3 North America Human Coagulation Factor VIII Price by Type (2019-2030)
8.2 North America Human Coagulation Factor VIII Market Size by Application
8.2.1 North America Human Coagulation Factor VIII Revenue by Application (2019-2030)
8.2.2 North America Human Coagulation Factor VIII Sales by Application (2019-2030)
8.2.3 North America Human Coagulation Factor VIII Price by Application (2019-2030)
8.3 North America Human Coagulation Factor VIII Market Size by Country
8.3.1 North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Human Coagulation Factor VIII Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Human Coagulation Factor VIII Market Size by Type
9.1.1 Europe Human Coagulation Factor VIII Revenue by Type (2019-2030)
9.1.2 Europe Human Coagulation Factor VIII Sales by Type (2019-2030)
9.1.3 Europe Human Coagulation Factor VIII Price by Type (2019-2030)
9.2 Europe Human Coagulation Factor VIII Market Size by Application
9.2.1 Europe Human Coagulation Factor VIII Revenue by Application (2019-2030)
9.2.2 Europe Human Coagulation Factor VIII Sales by Application (2019-2030)
9.2.3 Europe Human Coagulation Factor VIII Price by Application (2019-2030)
9.3 Europe Human Coagulation Factor VIII Market Size by Country
9.3.1 Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Human Coagulation Factor VIII Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Human Coagulation Factor VIII Market Size by Type
10.1.1 China Human Coagulation Factor VIII Revenue by Type (2019-2030)
10.1.2 China Human Coagulation Factor VIII Sales by Type (2019-2030)
10.1.3 China Human Coagulation Factor VIII Price by Type (2019-2030)
10.2 China Human Coagulation Factor VIII Market Size by Application
10.2.1 China Human Coagulation Factor VIII Revenue by Application (2019-2030)
10.2.2 China Human Coagulation Factor VIII Sales by Application (2019-2030)
10.2.3 China Human Coagulation Factor VIII Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Human Coagulation Factor VIII Market Size by Type
11.1.1 Asia Human Coagulation Factor VIII Revenue by Type (2019-2030)
11.1.2 Asia Human Coagulation Factor VIII Sales by Type (2019-2030)
11.1.3 Asia Human Coagulation Factor VIII Price by Type (2019-2030)
11.2 Asia Human Coagulation Factor VIII Market Size by Application
11.2.1 Asia Human Coagulation Factor VIII Revenue by Application (2019-2030)
11.2.2 Asia Human Coagulation Factor VIII Sales by Application (2019-2030)
11.2.3 Asia Human Coagulation Factor VIII Price by Application (2019-2030)
11.3 Asia Human Coagulation Factor VIII Market Size by Country
11.3.1 Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Human Coagulation Factor VIII Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Human Coagulation Factor VIII Market Size by Type
12.1.1 MEALA Human Coagulation Factor VIII Revenue by Type (2019-2030)
12.1.2 MEALA Human Coagulation Factor VIII Sales by Type (2019-2030)
12.1.3 MEALA Human Coagulation Factor VIII Price by Type (2019-2030)
12.2 MEALA Human Coagulation Factor VIII Market Size by Application
12.2.1 MEALA Human Coagulation Factor VIII Revenue by Application (2019-2030)
12.2.2 MEALA Human Coagulation Factor VIII Sales by Application (2019-2030)
12.2.3 MEALA Human Coagulation Factor VIII Price by Application (2019-2030)
12.3 MEALA Human Coagulation Factor VIII Market Size by Country
12.3.1 MEALA Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Human Coagulation Factor VIII Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Human Coagulation Factor VIII Value Chain Analysis
13.1.1 Human Coagulation Factor VIII Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Human Coagulation Factor VIII Production Mode & Process
13.2 Human Coagulation Factor VIII Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Human Coagulation Factor VIII Distributors
13.2.3 Human Coagulation Factor VIII Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Human Coagulation Factor VIII Market by Type
1.2.1 Global Human Coagulation Factor VIII Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII Market by Application
1.3.1 Global Human Coagulation Factor VIII Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HUMAN COAGULATION FACTOR VIII MARKET DYNAMICS
2.1 Human Coagulation Factor VIII Industry Trends
2.2 Human Coagulation Factor VIII Industry Drivers
2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
2.4 Human Coagulation Factor VIII Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Human Coagulation Factor VIII Revenue Estimates and Forecasts (2019-2030)
3.2 Global Human Coagulation Factor VIII Revenue by Region
3.2.1 Global Human Coagulation Factor VIII Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Human Coagulation Factor VIII Revenue by Region (2019-2024)
3.2.3 Global Human Coagulation Factor VIII Revenue by Region (2025-2030)
3.2.4 Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2030)
3.3 Global Human Coagulation Factor VIII Sales Estimates and Forecasts 2019-2030
3.4 Global Human Coagulation Factor VIII Sales by Region
3.4.1 Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Human Coagulation Factor VIII Sales by Region (2019-2024)
3.4.3 Global Human Coagulation Factor VIII Sales by Region (2025-2030)
3.4.4 Global Human Coagulation Factor VIII Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Human Coagulation Factor VIII Revenue by Manufacturers
4.1.1 Global Human Coagulation Factor VIII Revenue by Manufacturers (2019-2024)
4.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Human Coagulation Factor VIII Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Human Coagulation Factor VIII Sales by Manufacturers
4.2.1 Global Human Coagulation Factor VIII Sales by Manufacturers (2019-2024)
4.2.2 Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Human Coagulation Factor VIII Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Human Coagulation Factor VIII Sales Price by Manufacturers (2019-2024)
4.4 Global Human Coagulation Factor VIII Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Human Coagulation Factor VIII Manufacturers, Product Type & Application
4.7 Global Human Coagulation Factor VIII Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Human Coagulation Factor VIII Market CR5 and HHI
4.8.2 2023 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier
5 HUMAN COAGULATION FACTOR VIII MARKET BY TYPE
5.1 Global Human Coagulation Factor VIII Revenue by Type
5.1.1 Global Human Coagulation Factor VIII Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Human Coagulation Factor VIII Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2030)
5.2 Global Human Coagulation Factor VIII Sales by Type
5.2.1 Global Human Coagulation Factor VIII Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Human Coagulation Factor VIII Sales by Type (2019-2030) & (K Bottles)
5.2.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2030)
5.3 Global Human Coagulation Factor VIII Price by Type
6 HUMAN COAGULATION FACTOR VIII MARKET BY APPLICATION
6.1 Global Human Coagulation Factor VIII Revenue by Application
6.1.1 Global Human Coagulation Factor VIII Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Human Coagulation Factor VIII Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2030)
6.2 Global Human Coagulation Factor VIII Sales by Application
6.2.1 Global Human Coagulation Factor VIII Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Human Coagulation Factor VIII Sales by Application (2019-2030) & (K Bottles)
6.2.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2030)
6.3 Global Human Coagulation Factor VIII Price by Application
7 COMPANY PROFILES
7.1 Shire (Baxter)
7.1.1 Shire (Baxter) Comapny Information
7.1.2 Shire (Baxter) Business Overview
7.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
7.1.5 Shire (Baxter) Recent Developments
7.2 Bayer
7.2.1 Bayer Comapny Information
7.2.2 Bayer Business Overview
7.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
7.2.5 Bayer Recent Developments
7.3 CSL
7.3.1 CSL Comapny Information
7.3.2 CSL Business Overview
7.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 CSL Human Coagulation Factor VIII Product Portfolio
7.3.5 CSL Recent Developments
7.4 Pfizer
7.4.1 Pfizer Comapny Information
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
7.4.5 Pfizer Recent Developments
7.5 Grifols
7.5.1 Grifols Comapny Information
7.5.2 Grifols Business Overview
7.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
7.5.5 Grifols Recent Developments
7.6 Biogen
7.6.1 Biogen Comapny Information
7.6.2 Biogen Business Overview
7.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
7.6.5 Biogen Recent Developments
7.7 Octapharma
7.7.1 Octapharma Comapny Information
7.7.2 Octapharma Business Overview
7.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
7.7.5 Octapharma Recent Developments
7.8 NovoNordisk
7.8.1 NovoNordisk Comapny Information
7.8.2 NovoNordisk Business Overview
7.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
7.8.5 NovoNordisk Recent Developments
7.9 Greencross
7.9.1 Greencross Comapny Information
7.9.2 Greencross Business Overview
7.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
7.9.5 Greencross Recent Developments
7.10 Kedrion
7.10.1 Kedrion Comapny Information
7.10.2 Kedrion Business Overview
7.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
7.10.5 Kedrion Recent Developments
7.11 BPL
7.11.1 BPL Comapny Information
7.11.2 BPL Business Overview
7.11.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 BPL Human Coagulation Factor VIII Product Portfolio
7.11.5 BPL Recent Developments
7.12 Hualan Bio
7.12.1 Hualan Bio Comapny Information
7.12.2 Hualan Bio Business Overview
7.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
7.12.5 Hualan Bio Recent Developments
7.13 RAAS
7.13.1 RAAS Comapny Information
7.13.2 RAAS Business Overview
7.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
7.13.5 RAAS Recent Developments
8 NORTH AMERICA
8.1 North America Human Coagulation Factor VIII Market Size by Type
8.1.1 North America Human Coagulation Factor VIII Revenue by Type (2019-2030)
8.1.2 North America Human Coagulation Factor VIII Sales by Type (2019-2030)
8.1.3 North America Human Coagulation Factor VIII Price by Type (2019-2030)
8.2 North America Human Coagulation Factor VIII Market Size by Application
8.2.1 North America Human Coagulation Factor VIII Revenue by Application (2019-2030)
8.2.2 North America Human Coagulation Factor VIII Sales by Application (2019-2030)
8.2.3 North America Human Coagulation Factor VIII Price by Application (2019-2030)
8.3 North America Human Coagulation Factor VIII Market Size by Country
8.3.1 North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Human Coagulation Factor VIII Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Human Coagulation Factor VIII Market Size by Type
9.1.1 Europe Human Coagulation Factor VIII Revenue by Type (2019-2030)
9.1.2 Europe Human Coagulation Factor VIII Sales by Type (2019-2030)
9.1.3 Europe Human Coagulation Factor VIII Price by Type (2019-2030)
9.2 Europe Human Coagulation Factor VIII Market Size by Application
9.2.1 Europe Human Coagulation Factor VIII Revenue by Application (2019-2030)
9.2.2 Europe Human Coagulation Factor VIII Sales by Application (2019-2030)
9.2.3 Europe Human Coagulation Factor VIII Price by Application (2019-2030)
9.3 Europe Human Coagulation Factor VIII Market Size by Country
9.3.1 Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Human Coagulation Factor VIII Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Human Coagulation Factor VIII Market Size by Type
10.1.1 China Human Coagulation Factor VIII Revenue by Type (2019-2030)
10.1.2 China Human Coagulation Factor VIII Sales by Type (2019-2030)
10.1.3 China Human Coagulation Factor VIII Price by Type (2019-2030)
10.2 China Human Coagulation Factor VIII Market Size by Application
10.2.1 China Human Coagulation Factor VIII Revenue by Application (2019-2030)
10.2.2 China Human Coagulation Factor VIII Sales by Application (2019-2030)
10.2.3 China Human Coagulation Factor VIII Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Human Coagulation Factor VIII Market Size by Type
11.1.1 Asia Human Coagulation Factor VIII Revenue by Type (2019-2030)
11.1.2 Asia Human Coagulation Factor VIII Sales by Type (2019-2030)
11.1.3 Asia Human Coagulation Factor VIII Price by Type (2019-2030)
11.2 Asia Human Coagulation Factor VIII Market Size by Application
11.2.1 Asia Human Coagulation Factor VIII Revenue by Application (2019-2030)
11.2.2 Asia Human Coagulation Factor VIII Sales by Application (2019-2030)
11.2.3 Asia Human Coagulation Factor VIII Price by Application (2019-2030)
11.3 Asia Human Coagulation Factor VIII Market Size by Country
11.3.1 Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Human Coagulation Factor VIII Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Human Coagulation Factor VIII Market Size by Type
12.1.1 MEALA Human Coagulation Factor VIII Revenue by Type (2019-2030)
12.1.2 MEALA Human Coagulation Factor VIII Sales by Type (2019-2030)
12.1.3 MEALA Human Coagulation Factor VIII Price by Type (2019-2030)
12.2 MEALA Human Coagulation Factor VIII Market Size by Application
12.2.1 MEALA Human Coagulation Factor VIII Revenue by Application (2019-2030)
12.2.2 MEALA Human Coagulation Factor VIII Sales by Application (2019-2030)
12.2.3 MEALA Human Coagulation Factor VIII Price by Application (2019-2030)
12.3 MEALA Human Coagulation Factor VIII Market Size by Country
12.3.1 MEALA Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Human Coagulation Factor VIII Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Human Coagulation Factor VIII Value Chain Analysis
13.1.1 Human Coagulation Factor VIII Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Human Coagulation Factor VIII Production Mode & Process
13.2 Human Coagulation Factor VIII Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Human Coagulation Factor VIII Distributors
13.2.3 Human Coagulation Factor VIII Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Human Coagulation Factor VIII Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Recombinant Factor VIII Major Manufacturers
Table 3. Plasma-derived Factor VIII Major Manufacturers
Table 4. Global Human Coagulation Factor VIII Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Hemophilia A Major Manufacturers
Table 6. Spontanous / Trauma Major Manufacturers
Table 7. Surgical Major Manufacturers
Table 8. Other Major Manufacturers
Table 9. Human Coagulation Factor VIII Industry Trends
Table 10. Human Coagulation Factor VIII Industry Drivers
Table 11. Human Coagulation Factor VIII Industry Opportunities and Challenges
Table 12. Human Coagulation Factor VIII Industry Restraints
Table 13. Global Human Coagulation Factor VIII Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Human Coagulation Factor VIII Revenue by Region (2019-2024) & (US$ Million)
Table 15. Global Human Coagulation Factor VIII Revenue by Region (2025-2030) & (US$ Million)
Table 16. Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2024)
Table 17. Global Human Coagulation Factor VIII Revenue Market Share by Region (2025-2030)
Table 18. Global Human Coagulation Factor VIII Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Bottles)
Table 19. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)
Table 20. Global Human Coagulation Factor VIII Sales by Region (2025-2030) & (K Bottles)
Table 21. Global Human Coagulation Factor VIII Sales Market Share by Region (2019-2024)
Table 22. Global Human Coagulation Factor VIII Sales Market Share by Region (2025-2030)
Table 23. Global Human Coagulation Factor VIII Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2019-2024)
Table 25. Global Human Coagulation Factor VIII Sales by Manufacturers (US$ Million) & (2019-2024)
Table 26. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2019-2024)
Table 27. Global Human Coagulation Factor VIII Sales Price (USD/Bottle) of Manufacturers (2019-2024)
Table 28. Global Human Coagulation Factor VIII Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 29. Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
Table 30. Global Human Coagulation Factor VIII Manufacturers, Product Type & Application
Table 31. Global Human Coagulation Factor VIII Manufacturers Commercialization Time
Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Human Coagulation Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 34. Global Human Coagulation Factor VIII Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 36. Global Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 37. Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2024)
Table 38. Global Human Coagulation Factor VIII Revenue Market Share by Type (2025-2030)
Table 39. Global Human Coagulation Factor VIII Sales by Type 2019 VS 2023 VS 2030 (K Bottles)
Table 40. Global Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 41. Global Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 42. Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2024)
Table 43. Global Human Coagulation Factor VIII Sales Market Share by Type (2025-2030)
Table 44. Global Human Coagulation Factor VIII Price by Type (2019-2024) & (USD/Bottle)
Table 45. Global Human Coagulation Factor VIII Price by Type (2025-2030) & (USD/Bottle)
Table 46. Global Human Coagulation Factor VIII Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 47. Global Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 48. Global Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 49. Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2024)
Table 50. Global Human Coagulation Factor VIII Revenue Market Share by Application (2025-2030)
Table 51. Global Human Coagulation Factor VIII Sales by Application 2019 VS 2023 VS 2030 (K Bottles)
Table 52. Global Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 53. Global Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 54. Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2024)
Table 55. Global Human Coagulation Factor VIII Sales Market Share by Application (2025-2030)
Table 56. Global Human Coagulation Factor VIII Price by Application (2019-2024) & (USD/Bottle)
Table 57. Global Human Coagulation Factor VIII Price by Application (2025-2030) & (USD/Bottle)
Table 58. Shire (Baxter) Company Information
Table 59. Shire (Baxter) Business Overview
Table 60. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 61. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 62. Shire (Baxter) Recent Development
Table 63. Bayer Company Information
Table 64. Bayer Business Overview
Table 65. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 66. Bayer Human Coagulation Factor VIII Product Portfolio
Table 67. Bayer Recent Development
Table 68. CSL Company Information
Table 69. CSL Business Overview
Table 70. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 71. CSL Human Coagulation Factor VIII Product Portfolio
Table 72. CSL Recent Development
Table 73. Pfizer Company Information
Table 74. Pfizer Business Overview
Table 75. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 76. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 77. Pfizer Recent Development
Table 78. Grifols Company Information
Table 79. Grifols Business Overview
Table 80. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 81. Grifols Human Coagulation Factor VIII Product Portfolio
Table 82. Grifols Recent Development
Table 83. Biogen Company Information
Table 84. Biogen Business Overview
Table 85. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 86. Biogen Human Coagulation Factor VIII Product Portfolio
Table 87. Biogen Recent Development
Table 88. Octapharma Company Information
Table 89. Octapharma Business Overview
Table 90. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 91. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 92. Octapharma Recent Development
Table 93. NovoNordisk Company Information
Table 94. NovoNordisk Business Overview
Table 95. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 96. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 97. NovoNordisk Recent Development
Table 98. Greencross Company Information
Table 99. Greencross Business Overview
Table 100. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 101. Greencross Human Coagulation Factor VIII Product Portfolio
Table 102. Greencross Recent Development
Table 103. Kedrion Company Information
Table 104. Kedrion Business Overview
Table 105. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 106. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 107. Kedrion Recent Development
Table 108. BPL Company Information
Table 109. BPL Business Overview
Table 110. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 111. BPL Human Coagulation Factor VIII Product Portfolio
Table 112. BPL Recent Development
Table 113. Hualan Bio Company Information
Table 114. Hualan Bio Business Overview
Table 115. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 116. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 117. Hualan Bio Recent Development
Table 118. RAAS Company Information
Table 119. RAAS Business Overview
Table 120. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 121. RAAS Human Coagulation Factor VIII Product Portfolio
Table 122. RAAS Recent Development
Table 123. North America Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 124. North America Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 125. North America Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 126. North America Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 127. North America Human Coagulation Factor VIII Sales Price by Type (2019-2024) & (USD/Bottle)
Table 128. North America Human Coagulation Factor VIII Sales Price by Type (2025-2030) & (USD/Bottle)
Table 129. North America Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 130. North America Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 131. North America Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 132. North America Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 133. North America Human Coagulation Factor VIII Sales Price by Application (2019-2024) & (USD/Bottle)
Table 134. North America Human Coagulation Factor VIII Sales Price by Application (2025-2030) & (USD/Bottle)
Table 135. North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 136. North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 137. North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 138. North America Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030) & (K Bottles)
Table 139. North America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 140. North America Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 141. North America Human Coagulation Factor VIII Sales Price by Country (2019-2024) & (USD/Bottle)
Table 142. North America Human Coagulation Factor VIII Sales Price by Country (2025-2030) & (USD/Bottle)
Table 143. US Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 144. Canada Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 145. Europe Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 146. Europe Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 147. Europe Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 148. Europe Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 149. Europe Human Coagulation Factor VIII Sales Price by Type (2019-2024) & (USD/Bottle)
Table 150. Europe Human Coagulation Factor VIII Sales Price by Type (2025-2030) & (USD/Bottle)
Table 151. Europe Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 152. Europe Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 153. Europe Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 154. Europe Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 155. Europe Human Coagulation Factor VIII Sales Price by Application (2019-2024) & (USD/Bottle)
Table 156. Europe Human Coagulation Factor VIII Sales Price by Application (2025-2030) & (USD/Bottle)
Table 157. Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 158. Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 159. Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 160. Europe Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030) & (K Bottles)
Table 161. Europe Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 162. Europe Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 163. Europe Human Coagulation Factor VIII Sales Price by Country (2019-2024) & (USD/Bottle)
Table 164. Europe Human Coagulation Factor VIII Sales Price by Country (2025-2030) & (USD/Bottle)
Table 165. Germany Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 166. France Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 167. Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 168. Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 169. Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 170. China Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 171. China Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 172. China Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 173. China Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 174. China Human Coagulation Factor VIII Sales Price by Type (2019-2024) & (USD/Bottle)
Table 175. China Human Coagulation Factor VIII Sales Price by Type (2025-2030) & (USD/Bottle)
Table 176. China Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 177. China Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 178. China Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 179. China Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 180. China Human Coagulation Factor VIII Sales Price by Application (2019-2024) & (USD/Bottle)
Table 181. China Human Coagulation Factor VIII Sales Price by Application (2025-2030) & (USD/Bottle)
Table 182. Asia Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 183. Asia Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 184. Asia Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 185. Asia Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 186. Asia Human Coagulation Factor VIII Sales Price by Type (2019-2024) & (USD/Bottle)
Table 187. Asia Human Coagulation Factor VIII Sales Price by Type (2025-2030) & (USD/Bottle)
Table 188. Asia Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 189. Asia Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 190. Asia Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 191. Asia Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 192. Asia Human Coagulation Factor VIII Sales Price by Application (2019-2024) & (USD/Bottle)
Table 193. Asia Human Coagulation Factor VIII Sales Price by Application (2025-2030) & (USD/Bottle)
Table 194. Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 195. Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 196. Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 197.
Table 1. Global Human Coagulation Factor VIII Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Recombinant Factor VIII Major Manufacturers
Table 3. Plasma-derived Factor VIII Major Manufacturers
Table 4. Global Human Coagulation Factor VIII Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Hemophilia A Major Manufacturers
Table 6. Spontanous / Trauma Major Manufacturers
Table 7. Surgical Major Manufacturers
Table 8. Other Major Manufacturers
Table 9. Human Coagulation Factor VIII Industry Trends
Table 10. Human Coagulation Factor VIII Industry Drivers
Table 11. Human Coagulation Factor VIII Industry Opportunities and Challenges
Table 12. Human Coagulation Factor VIII Industry Restraints
Table 13. Global Human Coagulation Factor VIII Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Human Coagulation Factor VIII Revenue by Region (2019-2024) & (US$ Million)
Table 15. Global Human Coagulation Factor VIII Revenue by Region (2025-2030) & (US$ Million)
Table 16. Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2024)
Table 17. Global Human Coagulation Factor VIII Revenue Market Share by Region (2025-2030)
Table 18. Global Human Coagulation Factor VIII Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Bottles)
Table 19. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)
Table 20. Global Human Coagulation Factor VIII Sales by Region (2025-2030) & (K Bottles)
Table 21. Global Human Coagulation Factor VIII Sales Market Share by Region (2019-2024)
Table 22. Global Human Coagulation Factor VIII Sales Market Share by Region (2025-2030)
Table 23. Global Human Coagulation Factor VIII Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2019-2024)
Table 25. Global Human Coagulation Factor VIII Sales by Manufacturers (US$ Million) & (2019-2024)
Table 26. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2019-2024)
Table 27. Global Human Coagulation Factor VIII Sales Price (USD/Bottle) of Manufacturers (2019-2024)
Table 28. Global Human Coagulation Factor VIII Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 29. Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
Table 30. Global Human Coagulation Factor VIII Manufacturers, Product Type & Application
Table 31. Global Human Coagulation Factor VIII Manufacturers Commercialization Time
Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Human Coagulation Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 34. Global Human Coagulation Factor VIII Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 36. Global Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 37. Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2024)
Table 38. Global Human Coagulation Factor VIII Revenue Market Share by Type (2025-2030)
Table 39. Global Human Coagulation Factor VIII Sales by Type 2019 VS 2023 VS 2030 (K Bottles)
Table 40. Global Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 41. Global Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 42. Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2024)
Table 43. Global Human Coagulation Factor VIII Sales Market Share by Type (2025-2030)
Table 44. Global Human Coagulation Factor VIII Price by Type (2019-2024) & (USD/Bottle)
Table 45. Global Human Coagulation Factor VIII Price by Type (2025-2030) & (USD/Bottle)
Table 46. Global Human Coagulation Factor VIII Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 47. Global Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 48. Global Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 49. Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2024)
Table 50. Global Human Coagulation Factor VIII Revenue Market Share by Application (2025-2030)
Table 51. Global Human Coagulation Factor VIII Sales by Application 2019 VS 2023 VS 2030 (K Bottles)
Table 52. Global Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 53. Global Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 54. Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2024)
Table 55. Global Human Coagulation Factor VIII Sales Market Share by Application (2025-2030)
Table 56. Global Human Coagulation Factor VIII Price by Application (2019-2024) & (USD/Bottle)
Table 57. Global Human Coagulation Factor VIII Price by Application (2025-2030) & (USD/Bottle)
Table 58. Shire (Baxter) Company Information
Table 59. Shire (Baxter) Business Overview
Table 60. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 61. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 62. Shire (Baxter) Recent Development
Table 63. Bayer Company Information
Table 64. Bayer Business Overview
Table 65. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 66. Bayer Human Coagulation Factor VIII Product Portfolio
Table 67. Bayer Recent Development
Table 68. CSL Company Information
Table 69. CSL Business Overview
Table 70. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 71. CSL Human Coagulation Factor VIII Product Portfolio
Table 72. CSL Recent Development
Table 73. Pfizer Company Information
Table 74. Pfizer Business Overview
Table 75. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 76. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 77. Pfizer Recent Development
Table 78. Grifols Company Information
Table 79. Grifols Business Overview
Table 80. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 81. Grifols Human Coagulation Factor VIII Product Portfolio
Table 82. Grifols Recent Development
Table 83. Biogen Company Information
Table 84. Biogen Business Overview
Table 85. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 86. Biogen Human Coagulation Factor VIII Product Portfolio
Table 87. Biogen Recent Development
Table 88. Octapharma Company Information
Table 89. Octapharma Business Overview
Table 90. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 91. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 92. Octapharma Recent Development
Table 93. NovoNordisk Company Information
Table 94. NovoNordisk Business Overview
Table 95. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 96. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 97. NovoNordisk Recent Development
Table 98. Greencross Company Information
Table 99. Greencross Business Overview
Table 100. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 101. Greencross Human Coagulation Factor VIII Product Portfolio
Table 102. Greencross Recent Development
Table 103. Kedrion Company Information
Table 104. Kedrion Business Overview
Table 105. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 106. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 107. Kedrion Recent Development
Table 108. BPL Company Information
Table 109. BPL Business Overview
Table 110. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 111. BPL Human Coagulation Factor VIII Product Portfolio
Table 112. BPL Recent Development
Table 113. Hualan Bio Company Information
Table 114. Hualan Bio Business Overview
Table 115. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 116. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 117. Hualan Bio Recent Development
Table 118. RAAS Company Information
Table 119. RAAS Business Overview
Table 120. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 121. RAAS Human Coagulation Factor VIII Product Portfolio
Table 122. RAAS Recent Development
Table 123. North America Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 124. North America Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 125. North America Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 126. North America Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 127. North America Human Coagulation Factor VIII Sales Price by Type (2019-2024) & (USD/Bottle)
Table 128. North America Human Coagulation Factor VIII Sales Price by Type (2025-2030) & (USD/Bottle)
Table 129. North America Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 130. North America Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 131. North America Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 132. North America Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 133. North America Human Coagulation Factor VIII Sales Price by Application (2019-2024) & (USD/Bottle)
Table 134. North America Human Coagulation Factor VIII Sales Price by Application (2025-2030) & (USD/Bottle)
Table 135. North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 136. North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 137. North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 138. North America Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030) & (K Bottles)
Table 139. North America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 140. North America Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 141. North America Human Coagulation Factor VIII Sales Price by Country (2019-2024) & (USD/Bottle)
Table 142. North America Human Coagulation Factor VIII Sales Price by Country (2025-2030) & (USD/Bottle)
Table 143. US Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 144. Canada Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 145. Europe Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 146. Europe Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 147. Europe Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 148. Europe Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 149. Europe Human Coagulation Factor VIII Sales Price by Type (2019-2024) & (USD/Bottle)
Table 150. Europe Human Coagulation Factor VIII Sales Price by Type (2025-2030) & (USD/Bottle)
Table 151. Europe Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 152. Europe Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 153. Europe Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 154. Europe Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 155. Europe Human Coagulation Factor VIII Sales Price by Application (2019-2024) & (USD/Bottle)
Table 156. Europe Human Coagulation Factor VIII Sales Price by Application (2025-2030) & (USD/Bottle)
Table 157. Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 158. Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 159. Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 160. Europe Human Coagulation Factor VIII Sales by Country (2019 VS 2023 VS 2030) & (K Bottles)
Table 161. Europe Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 162. Europe Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 163. Europe Human Coagulation Factor VIII Sales Price by Country (2019-2024) & (USD/Bottle)
Table 164. Europe Human Coagulation Factor VIII Sales Price by Country (2025-2030) & (USD/Bottle)
Table 165. Germany Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 166. France Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 167. Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 168. Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 169. Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Table 170. China Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 171. China Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 172. China Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 173. China Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 174. China Human Coagulation Factor VIII Sales Price by Type (2019-2024) & (USD/Bottle)
Table 175. China Human Coagulation Factor VIII Sales Price by Type (2025-2030) & (USD/Bottle)
Table 176. China Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 177. China Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 178. China Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 179. China Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 180. China Human Coagulation Factor VIII Sales Price by Application (2019-2024) & (USD/Bottle)
Table 181. China Human Coagulation Factor VIII Sales Price by Application (2025-2030) & (USD/Bottle)
Table 182. Asia Human Coagulation Factor VIII Revenue by Type (2019-2024) & (US$ Million)
Table 183. Asia Human Coagulation Factor VIII Revenue by Type (2025-2030) & (US$ Million)
Table 184. Asia Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 185. Asia Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 186. Asia Human Coagulation Factor VIII Sales Price by Type (2019-2024) & (USD/Bottle)
Table 187. Asia Human Coagulation Factor VIII Sales Price by Type (2025-2030) & (USD/Bottle)
Table 188. Asia Human Coagulation Factor VIII Revenue by Application (2019-2024) & (US$ Million)
Table 189. Asia Human Coagulation Factor VIII Revenue by Application (2025-2030) & (US$ Million)
Table 190. Asia Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 191. Asia Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 192. Asia Human Coagulation Factor VIII Sales Price by Application (2019-2024) & (USD/Bottle)
Table 193. Asia Human Coagulation Factor VIII Sales Price by Application (2025-2030) & (USD/Bottle)
Table 194. Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 195. Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 196. Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 197.
